Methods of treating cancer with an antibody-drug conjugate
US8034959B2 · kind B2 · utility
30Cited by
127References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2009 |
| Grant date | Oct 11, 2011 |
| Priority date | — |
| Expiry date | Mar 2, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides analogues of duocarmycins that are potent cytotoxins. Also provided are peptidyl and disulfide linkers that are cleaved in vivo. The linkers are of use in forming prodrugs and conjugates of the cytotoxins of the invention as well as other diagnostic and therapeutic moieties. The invention provides prodrugs and conjugates of the duocarmycin analogues with the linker arms of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.